With the COVID virus raging worldwide and throughout the world, the world is indeed looking for a solution. Every country has been badly affected, like the United States and India. Despite being the world’s wealthiest country, the USA has approximately two lakh deaths and up to six and a half million affected cases. The second most populated country globally, India has around five million patients and is increasing daily. There is a serious debate going around in the United States about the American healthcare system’s rottenness.
As per the latest statistics, there are approx thirty million Americans who are uninsured. Due to the pandemic, almost 40 percent of the American workforce has lost their jobs. Since most US employees have employer-sponsored health insurance, most of them cannot access hospitals and doctors when unemployed, due to less no of positions. In India, due to lax rules of lockdown in the initial phase, and massive migration from cities to villages, rural labor, and workers, the virus has spread rapidly to the towns, from its earlier prevalence in the cities.
Apart from India and the United States, cases are soaring in Brazil’s largest Latin American country. Currently, Brazil has more than four million patients and with almost one hundred and fifty thousand deaths. Realizing the urgency of the situation worldwide, pharmaceutical firms globally are working nonstop to bring out an effective medicine for COVID-19. World-class firms like Astra Zeneca, Pfizer, Patanjali, Merck are expected to bring out a vaccine for COVID disease by the end of the year. Now, list the best five vaccines which are expected to change the future.
Remdisivir is the most famous medicine developed almost ten years ago, but it couldn’t clear clinical trials against the dreaded Ebola virus in 2014. The drug was perfectly safe while undergoing trials. The scientific body conducted a test, with a disease known as MERS, caused by different COVID. The results displayed that the drug blocked the virus from multiplying. The drug is always tested for lots of COVID-19 trials globally. Remdisivir is also being tested in small children, who have less to severe COVID-19.
EIDD-2801 is a drug that was created by Emory University-owned biotech company’s scientists. The research was undertaken in the mouse, which has exhibited that the drug Remsidivir can reduce the risk of multiple coronavirus multiplying, consisting of SARS-CoV2. The pharma firm Ridgeback Biotherapeutics LP and Merck signed a deal for creating this drug. EIDD-2801 is already under clinical trials in Britain and can also be taken orally.
Two drugs combine to form Kaletra, namely ritonavir and Lopinavir. These drugs couldn’t succeed against HIV. Unfortunately, Kaletra failed in clinical trials in mild, severe, and moderate COVID-19 testing. Once you combine Kaletra with Interferon beta 1b and Ribavirin, the process of cleaning the virus from the human body is much faster. This drug Kaletra is under trial clinically, to check whether it is effective against the virus SARS-COV2.
Favipiravir was sent by the Japanese government as a drug to prevent the Ebola Virus from spreading. As per reports, the drug can also be used to fight the dreaded coronavirus. So, Favipiravir has also been sent to more than forty-three countries for clinical trials regarding severe and moderate COVID-19. Favipiravir is ideal for homes where there is long term care since it can be consumed as a tablet.
5) Merimepodib ( VX- 497 ).
Merimepodib has the potential to depict immune reduction and antiviral effects. This drug was tested against hepatitis C but only had a small impact. ViralClear Pharmaceuticals Inc is used to develop this medicine and is under the phase II trial. At the end of this year, the firm can expect results. The patients who are suffering from advanced COVID-19 will get either Remdesivir + Placebo or Merimepodib with remdesivir. The Serum Institute of India collaborates with Astra Zeneca to make the vaccine for middle income and low-income nations. Merimepodib is under trial in Brazil, South Africa, and the UK. The patients are given the vaccine with a gap of two months.
One can only hope that out of these five vaccines, minimum one or two vaccines will be available quickly, which can rapidly curb the spread of COVID-19. We expect that the vaccine prices should be less and well within an average reach of a consumer. Every country is spending a tremendous amount of money on research and is in the race to quickly develop the vaccine. It can be safely stated that the inventor of the COVID-19 vaccine will be awarded the Noble Prize for Medicine in 2021. Experts say that the medical world hasn’t faced such a challenge within a century, ever since the Spanish Flu happened in the 1920’s.
The COVID virus has become a vital issue in the November elections in the United States. Due to the large no of deaths due to this virus, the US authorities are seriously thinking of introducing Universal Healthcare, just like in Asia and Europe. The point of contention is the high amount of taxation, which will be involved. During the recession, Americans are already fed up with the present high taxes and do not wish to pay any more. Both President Trump and Joe Biden have made Universal Healthcare a contention point in the November elections. Let us wait and analyze.